Schizophrenia

There are 565 papers on schizophrenia in aging research: 50 trials and 318 observational studies in people, 11 in animals, 2 in cells, 147 reviews. The newest story, Nov 7, 2026: “No clear antipsychotic–death link in schizophrenia with dementia”.

Disease

565 papers study it289 more mention it243 findings

MeSH

33 new papers in 30 daysSee all 854 papers on schizophrenia

At a glance

Schizophrenia is linked with shorter lifespan, frailty, dementia and higher brain-predicted age in human studies. Epigenetic aging associations differ: higher PhenoAge acceleration is linked with schizophrenia, but a study reports a lower blood Horvath clock in drug-naive, first-episode patients, and frontal-cortex studies show no clear link with epigenetic age or its acceleration.

243 findings in 171 papers from 2015 to 2026, 22 of them since April 2026

“Individuals with schizophrenia and elderly had slower Movement Time (MT)s compared with controls in all tasks”
Motor learning and performance in schizophrenia and aging: two different patterns of declineExperimental brain research2024doi:10.1007/s00221-024-06797-9
  • Human trial50
  • Humans318
  • Animals11
  • Cells2
  • In silico34

Effects

60

Telomere length

downin humans6no changein humans2

6 studies
  1. Schizophrenia was not clearly linked with telomere length in humans (schizophrenia vs controls).

    “No alterations in telomere length were found in MFG gray and white matter and in STG gray matter.”

    Humansschizophrenia vs controlsmedial frontal gyrus and superior temporal gyrus gray matter

    Telomere quantification in frontal and temporal brain tissue of patients with schizophrenia

    Journal of psychiatric research

  2. Schizophrenia is linked with lower telomere length in humans (schizophrenia vs controls) (fold change of -0.42, U = 5, P = 0.008).

    “A significant reduction in telomere length was observed in STG white matter of patients with schizophrenia as compared to controls (fold change of -0.42, U = 5, P = 0.008).”

    Humansschizophrenia vs controlssuperior temporal gyrus white matter

    Telomere quantification in frontal and temporal brain tissue of patients with schizophrenia

    Journal of psychiatric research

  3. Schizophrenia is linked with lower telomere length in humans (compared to healthy controls).

    “Participants with SZ had decreased TL and GM volume, increased CCL11, and worse memory performance compared to HC.”

    Humanscompared to healthy controlsperipheral bloodn = 112

    Telomere Length and CCL11 Levels are Associated With Gray Matter Volume and Episodic Memory Performance in Schizophrenia: Evidence of Pathological Accelerated Aging

    Schizophrenia bulletin

  4. Schizophrenia is linked with lower telomere length in humans (t(249) = 2.43, p = 0.016).

    “at the average sample age, women with schizophrenia had shorter LTL than HC women.”

    Humansbloodfemales

    Leukocyte telomere length: Effects of schizophrenia, age, and gender

    Journal of psychiatric research

  5. Schizophrenia was not clearly linked with telomere length in humans (non-paranoid schizophrenia) (F = 0.842, P = 0.360).

    “there was no significant difference in LTL between non-paranoid schizophrenia and controls (F = 0.842, P = 0.360)”

    Humansnon-paranoid schizophrenia

    Accelerated leukocyte telomere erosion in schizophrenia: Evidence from the present study and a meta-analysis

    Journal of psychiatric research

  6. Schizophrenia is linked with lower telomere length in humans (paranoid schizophrenia) (F = 50.88, P < 0.001).

    “significant reduction of LTL in paranoid schizophrenia was observed compared to controls (F = 50.88, P < 0.001)”

    Humansparanoid schizophrenia

    Accelerated leukocyte telomere erosion in schizophrenia: Evidence from the present study and a meta-analysis

    Journal of psychiatric research

  7. Schizophrenia decreases telomere length in humans (relative to healthy controls) (ES -0.388, 95% CI -0.492 to -0.283, p < 0.001).

    “showed that LTL was significantly shorter in patients, with a small to medium effect size (ES, -0.388; 95% CI, -0.492 to -0.283; p < 0.001).”

    Reviewrelative to healthy controls

    Leukocyte telomere length in patients with schizophrenia and related disorders: a meta-analysis of case-control studies

    Molecular psychiatry

  8. Schizophrenia decreases telomere length in humans (compared with control subjects).

    “To date, the majority of the studies and meta-analyses found a decrease in TL in subjects with schizophrenia compared to control subjects.”

    Reviewcompared with control subjects

    Accelerated telomere erosion in schizophrenia: A literature review

    L'Encephale

More on Telomere length

Epigenetic age

downin humans2no changein humans1downin silico1

4 studies
  1. Schizophrenia is linked with lower epigenetic age in older adults with schizophrenia (-3.171 vs 2.418, P < 0.05).

    “a decelerated epigenetic aging process was observed in the CB region of individuals with SCZ aged 50-70 years (AgeAccel of SCZ vs control: -3.171 vs 2.418; P < 0.05)”

    Humansin older adults with schizophreniacerebellum

    Epigenetic analysis suggests aberrant cerebellum brain aging in old-aged adults with autism spectrum disorder and schizophrenia

    Molecular psychiatry

  2. Schizophrenia is linked with lower epigenetic age in humans (schizophrenia vs unaffected controls).

    “we observed that epigenetic age acceleration was significantly delayed in schizophrenia from the whole blood samples (aged 20-90 years) and brain frontal cortex tissues (aged 20-39 years)”

    Humansschizophrenia vs unaffected controls

    Epigenetic Age Acceleration Was Delayed in Schizophrenia

    Schizophrenia bulletin

  3. Schizophrenia was not clearly linked with epigenetic age in subjects with schizophrenia vs controls (t=0.52, p=0.60).

    “DNAm age acceleration did not differ between NPC and SZ subjects in the brain dataset (t=0.52, p=0.60)”

    Humansin subjects with schizophrenia vs controlsdorsolateral prefrontal cortex

    DNA methylation age is not accelerated in brain or blood of subjects with schizophrenia

    Schizophrenia research

  4. Schizophrenia decreases epigenetic age in silico.

    “Epigenetic age acceleration was reduced in schizophrenia”

    In silico

    Recalibrating the epigenetic clock reveals divergent DNA methylation age signatures across schizophrenia, bipolar disorder and major depressive disorder

    The British journal of psychiatry : the journal of mental science

More on Epigenetic age

Cognitive function

downin humans4

4 studies
  1. Schizophrenia impairs cognitive function in humans.

    “performed less well on cognitive tests including the verbal learning task”

    Human trial

    Motor learning and performance in schizophrenia and aging: two different patterns of decline

    Experimental brain research

  2. Schizophrenia is linked with worse cognitive function in late-life schizophrenia patients vs healthy controls (all p ≤ 0.005).

    “The cognitive performance of LLS patients was worse than that of the controls on RBANS total score and scores of immediate memory, attention, language, and delayed memory (all p ≤ 0.005).”

    Humansin late-life schizophrenia patients vs healthy controls

    Decreased Peripheral BDNF Levels and Cognitive Impairment in Late-Life Schizophrenia

    Frontiers in psychiatry

  3. Schizophrenia is linked with worse cognitive function in humans.

    “People with schizophrenia performed significantly worse on all tests, as expected, indicating widespread cognitive deficits compared to healthy individuals, independent of age.”

    Humans

    Schizophrenia, cognition, and aging: cognitive deficits and the relationship between test performance and aging

    Neuropsychology, development, and cognition. Section B, Aging, neuropsychology and cognition

  4. Schizophrenia impairs cognitive function in humans.

    “Recent evidence supports accelerated cognitive decline and brain changes in middle-aged and older people with schizophrenia, relative to the general population.”

    Review

    Dementia among older people with schizophrenia: an update on recent studies

    Current opinion in psychiatry

Horvath clock

downin humans2no changein human cells1

3 studies
  1. Schizophrenia is linked with lower Horvath clock in humans (schizophrenia cases compared to controls).

    “intrinsic cellular age (Horvath clock) is decelerated in SCZ cases in young adulthood”

    Humansschizophrenia cases compared to controls

    Meta-analysis of epigenetic aging in schizophrenia reveals multifaceted relationships with age, sex, illness duration, and polygenic risk

    Clinical epigenetics

  2. Schizophrenia is linked with lower Horvath clock in humans.

    “Multiple regression analyses found a significant difference between FSCZ patients and healthy controls in Horvath’s AgeAccel (β = − 0.28, p = 0.01), but not in Hannum’s AgeAccel (β = − 0.21, p = 0.07) and Levine’s PhenoAgeAccel (β = − 0.09, p = 0.42).”

    Humans8 weeks

    Epigenetic clock analysis of blood samples in drug-naive first-episode schizophrenia patients

    BMC psychiatry

  3. Schizophrenia is linked with lower Horvath clock in humans (drug-naive first-episode schizophrenia vs healthy controls) (p = 0.01).

    “Compared with healthy controls, drug-naive FSCZ patients have a significant epigenetic age deceleration in Horvath clock (p = 0.01)”

    Humansdrug-naive first-episode schizophrenia vs healthy controlsblood

    Epigenetic clock analysis of blood samples in drug-naive first-episode schizophrenia patients

    BMC psychiatry

  4. Schizophrenia showed no clear effect on Horvath clock in human cells (postmortem superior temporal gyrus) (t = 1.27, p = 0.21).

    “Age acceleration did not differ between non-psychiatric control and schizophrenia subjects (t = 1.27, p = 0.21).”

    Cellspostmortem superior temporal gyrus

    DNA methylation evidence against the accelerated aging hypothesis of schizophrenia

    NPJ schizophrenia

More on Horvath clock

Brain age

upin humans3

3 studies
  1. Schizophrenia is linked with higher brain age in humans (compared to normal controls).

    “Furthermore, the application to multi-center schizophrenia data shows a mean accelerated aging compared to normal controls.”

    Humanscompared to normal controls

    Multi-center brain age prediction via dual-modality fusion convolutional network

    Medical image analysis

  2. Schizophrenia is linked with higher brain age in humans (compared with healthy controls).

    “Accelerated brain aging was identified in patients with SCZ, FE-SSDs, and TRS compared with the HCs.”

    Humanscompared with healthy controls

    Stage-Specific Brain Aging in First-Episode Schizophrenia and Treatment-Resistant Schizophrenia

    The international journal of neuropsychopharmacology

  3. Schizophrenia is linked with higher brain age in humans (8 years greater in sample 1; 6 years greater in sample 2).

    “Predicted age was 8 years greater than chronological age in individuals with schizophrenia in the first sample and 6 years greater in the second sample.”

    Humans

    Brain structure, cognition, and brain age in schizophrenia, bipolar disorder, and healthy controls

    Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology

More on Brain age

Lifespan

downin humans2

2 studies
  1. Schizophrenia is linked with lower lifespan in humans (schizophrenia vs nonpsychiatric controls) (63.4 +/- 2.63 vs 84.0 +/- 0.57 years, p<0.001).

    “The mean age at death was significantly younger in schizophrenic patients (63.4 +/- 2.63 years) than in nonpsychiatric patients (84.0 +/- 0.57 years) (p<0.001).”

    Humansschizophrenia vs nonpsychiatric controls

    Deceased Schizophrenic Patients--Focus on QT Prolongation

    Seishin shinkeigaku zasshi = Psychiatria et neurologia Japonica

  2. Schizophrenia shortens lifespan in schizophrenia.

    “associated with substantially shortened life expectancy”

    Reviewin schizophrenia

    Accelerated aging in schizophrenia: integrating epigenetic clocks, telomere dynamics, senescence-associated secretory phenotype, and oxidative stress

    European archives of psychiatry and clinical neuroscience

Frailty

upin humans1upin silico1OR 1.019

2 studies
  1. Schizophrenia is linked with higher frailty in humans (OR 1.019, 95% CI 1.005-1.033).

    “Genetically predicted SCZ (odds ratio [OR] = 1.019, 95% confidence interval [CI] 1.005-1.033) and MDD (OR = 1.211, 95% CI 1.092-1.343) had significant causal effects on FI.”

    Humans

    Causal relationship between genetically predicted mental disorders and frailty: a bidirectional and multivariable mendelian randomization study

    BMC psychiatry

  2. Schizophrenia increases frailty in silico (β: 0.012, 95% CI: 0.006-0.018, p < 0.001).

    “and vice versa (β: 0.012, 95% CI: 0.006-0.018, p < 0.001)”

    In silico

    Shared genetic architecture and causal relationship between frailty and schizophrenia

    Schizophrenia (Heidelberg, Germany)

Brain age gap

no changein humans1upin humans1

2 studies
  1. Schizophrenia was not clearly linked with brain age gap in functional connectivity maps.

    “However, no accelerated brain aging was noted in the FC maps.”

    Humansin functional connectivity mapsbrain

    Investigating brain aging trajectory deviations in different brain regions of individuals with schizophrenia using multimodal magnetic resonance imaging and brain-age prediction: a multicenter study

    Translational psychiatry

  2. Schizophrenia increases brain age gap in humans (relative to age-matched controls) (3.08 (95% CI 2.32-3.85), p < 0.01).

    “schizophrenia (3.08; 95%CI [2.32; 3.85]; p < 0.01) presenting the largest effect”

    Reviewrelative to age-matched controlsbrain

    Brain age in mood and psychotic disorders: a systematic review and meta-analysis

    Acta psychiatrica Scandinavica

More on Brain age gap

Cortical thickness

downin humans2

2 studies
  1. Schizophrenia is linked with lower cortical thickness in humans (relative to healthy controls; first-episode, treatment-naïve patients).

    “patients exhibited a significantly smaller age-related cortical thickness in the anterior cingulate, inferior temporal, and insular gyri in the right hemisphere”

    Humansrelative to healthy controls; first-episode, treatment-naïve patientsright anterior cingulate, inferior temporal, and insular gyri

    Age-Related Reduction in Cortical Thickness in First-Episode Treatment-Naïve Patients with Schizophrenia

    Neuroscience bulletin

  2. Schizophrenia is linked with lower cortical thickness in humans.

    “Participants with schizophrenia had lower cortical thickness and FA compared with the other two groups”

    Humansfronto-temporal circuitry

    Brain structure, cognition, and brain age in schizophrenia, bipolar disorder, and healthy controls

    Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology

More on Cortical thickness

Retinal age gap

no changein humans1upin humans1

1 study
  1. Schizophrenia was not clearly linked with retinal age gap in humans (adjusting for hypertension and diabetes mellitus) (0.20, 95% CI: -0.53, 0.93).

    “When adjusting for hypertension and diabetes mellitus, there was no significant difference in retinal age gap between groups (0.20, 95% CI: -0.53, 0.93).”

    Humansadjusting for hypertension and diabetes mellitusn = 98,629

    The association of retinal age gap with schizophrenia: a cross-sectional analysis

    Schizophrenia research

  2. Schizophrenia is linked with higher retinal age gap in humans (adjusting for age, sex, ethnicity, and socioeconomic status) (0.76 years, 95% CI: 0.03, 1.49, p=0.04).

    “Individuals with schizophrenia had a significantly greater retinal age gap (0.76 years, 95% CI: 0.03, 1.49, p=0.04) when adjusting for age, sex, ethnicity, and socioeconomic status.”

    Humansadjusting for age, sex, ethnicity, and socioeconomic statusn = 98,629

    The association of retinal age gap with schizophrenia: a cross-sectional analysis

    Schizophrenia research

More on Retinal age gap

Sensorimotor adaptation

downin humans1

1 study
  1. Schizophrenia impairs sensorimotor adaptation in humans.

    “individuals with schizophrenia adapted slower and to a lesser extent to movement perturbations in adaptation tasks”

    Human trial

    Motor learning and performance in schizophrenia and aging: two different patterns of decline

    Experimental brain research

Movement time

upin humans1

1 study
  1. Schizophrenia increases movement time in humans.

    “Individuals with schizophrenia and elderly had slower Movement Time (MT)s compared with controls in all tasks”

    Human trial

    Motor learning and performance in schizophrenia and aging: two different patterns of decline

    Experimental brain research

All 60

Upstream

3

PhenoAgeAccel

mediatesin humans1

1 study
  1. PhenoAgeAccel is linked with schizophrenia in the pathway from air pollution to schizophrenia (3-5 %).

    “and 3-5 % of its association with SCZ.”

    Humansin the pathway from air pollution to schizophrenian = 483,482

    Association between biological aging and genetic susceptibility with the risk of bipolar disorder and schizophrenia: A prospective cohort study

    Journal of affective disorders

More on PhenoAgeAccel

Frailty index

no changein humans1

1 study
  1. Frailty index was not clearly linked with schizophrenia in humans.

    “Schizophrenia indicated no significant causal association.”

    Humans

    Bidirectional causal association between frailty and six psychiatric disorders

    European archives of psychiatry and clinical neuroscience

More on Frailty index

Cortisol

no changein humans1

1 study
  1. Cortisol was not clearly linked with schizophrenia in humans (genetically predicted plasma cortisol).

    “There was no evidence of association with type 2 diabetes, osteoporosis, depression and schizophrenia.”

    Humansgenetically predicted plasma cortisol

    Genetically predicted plasma cortisol and common chronic diseases: A Mendelian randomization study

    Clinical endocrinology

More on Cortisol

Associations

125

Dementia

upin humans7no changein humans1HR 1.86–2.87

8 studies
  1. Schizophrenia is linked with a higher risk of dementia in people living with HIV (HR = 2.49, 95% CI: 1.85 to 3.35).

    “PLWH and schizophrenia, were found to have a 2.49 higher hazard of dementia than HIV patients with no history of schizophrenia or antipsychotic medication use (hazard ratio [HR] = 2.49, 95% confidence interval [CI]: 1.85 to 3.35).”

    Humansin people living with HIV

    Schizophrenia, Off-Label Antipsychotics, and Dementia Risk in People With HIV

    Journal of acquired immune deficiency syndromes (1999)

  2. Schizophrenia is linked with a higher risk of dementia in humans (HR 2.87).

    “Psychiatric disorders, except anxiety, were highly significantly associated with a subsequent diagnosis of dementia: HRs=2.87, 2.80, 1.63 for schizophrenia, mania/bipolar disorder and depression, respectively.”

    Humans

    Severe psychiatric disorders are associated with increased risk of dementia

    BMJ mental health

  3. Schizophrenia is associated with dementia in humans (older adults receiving interRAI assessments) (23% vs 25%).

    “the difference from rate of dementia in individuals with schizophrenia was not statistically significant.”

    Humansolder adults receiving interRAI assessmentsn = 168,780

    Older adults with schizophrenia and dementia: Analysis of a national dataset

    Australasian journal on ageing

  4. Schizophrenia is linked with a higher risk of dementia in patients with atrial fibrillation (HR 1.86, 95% CI 1.75 to 1.98).

    “schizophrenia (HR 1.86, 95% CI 1.75 to 1.98)”

    Humansin patients with atrial fibrillation

    Risk Factors for Dementia in Patients With Atrial Fibrillation

    The American journal of cardiology

  5. Schizophrenia is associated with dementia in humans.

    “Odds of dementia diagnosis are significantly greater for beneficiaries diagnosed with SZP, BPD, or MDD.”

    Humansn = 18,740

    Estimating the Prevalence of Serious Mental Illness and Dementia Diagnoses Among Medicare Beneficiaries in the Health and Retirement Study

    Research on aging

  6. Schizophrenia raises the risk of dementia in humans (two- to threefold increased risk).

    “Epidemiological studies consistently indicate a two- to threefold increased risk of dementia among individuals with schizophrenia”

    Review

    Schizophrenia and dementia across the lifespan: epidemiological links, cognitive trajectories, and the pathophysiological interplay

    Frontiers in neurology

  7. Schizophrenia is associated with dementia in humans.

    “strength of association varies among different psychiatric conditions, being more pronounced in severe mental illnesses, i.e., schizophrenia and bipolar disorder.”

    Review

    The conundrum of the connection between severe psychiatric disorders and dementia

    Dementia & neuropsychologia

  8. Schizophrenia raises the risk of dementia in humans (compared with general population).

    “People with schizophrenia have high rates of dementia, compared with the general population”

    Reviewcompared with general population

    Dementia among older people with schizophrenia: an update on recent studies

    Current opinion in psychiatry

More on Dementia

Frailty

upin humans4upin silico3OR 1.02–1.91

7 studies
  1. Schizophrenia is associated with frailty in humans.

    “Compared to healthy controls, patients with schizophrenia showed significantly higher scores on FI-Lab, EFS, and CFS.”

    Humans

    Frailty-related vulnerability and immune cell profiles in younger adults with schizophrenia: an exploratory study

    BMC psychiatry

  2. Schizophrenia is associated with frailty in humans (adjusted model) (β = 0.044, p = 0.004).

    “Schizophrenia was significantly associated with FI-Lab (β = 0.044, p = 0.004) in the adjusted model.”

    Humansadjusted model

    Accelerated pace of frailty in patients with schizophrenia

    The journal of nutrition, health & aging

  3. Schizophrenia is associated with frailty in pre-old patients with schizophrenia vs healthy controls.

    “The Frailty Index-laboratory scores of participants with schizophrenia were higher than those of healthy controls significantly.”

    Humansin pre-old patients with schizophrenia vs healthy controls

    Early identification of characteristics of frailty in pre-old patients with schizophrenia based on use of frailty index-laboratory results and immune-inflammatory markers

    Preprint

  4. Schizophrenia is associated with frailty in humans (patients with hip fracture) (53.7% vs 34.2%).

    “A higher proportion of patients with vs without schizophrenia had frailty (53.7% vs 34.2%; standardized difference, 0.40)”

    Humanspatients with hip fracturen = 109,908

    Characterization of Hip Fractures Among Adults With Schizophrenia in Ontario, Canada

    JAMA network open

  5. Frailty raises the risk of schizophrenia in silico (OR: 1.763, 95% CI: 1.259-2.468, p = 0.001).

    “MR analysis suggests that frailty increases the likelihood of schizophrenia (OR: 1.763, 95% CI: 1.259-2.468, p = 0.001)”

    In silico

    Shared genetic architecture and causal relationship between frailty and schizophrenia

    Schizophrenia (Heidelberg, Germany)

  6. Frailty raises the risk of schizophrenia in silico (OR = 1.91, PIVW = 0.005).

    “schizophrenia (OR = 1.91, PIVW = 0.005)”

    In silico

    Association between frailty and common psychiatric disorders: A bidirectional Mendelian randomization study

    Journal of affective disorders

  7. Schizophrenia raises the risk of frailty in silico (OR = 1.02, 95% CI 1.01-1.04).

    “schizophrenia (OR = 1.02, 95% CI 1.01-1.04, P = 1.70E-03) with FI”

    In silico

    Bidirectional causal relational between frailty and mental illness: a two-sample Mendelian randomization study

    Frontiers in psychiatry

Telomere length

downin humans5downin reviews1

6 studies
  1. Schizophrenia is associated with telomere length in humans (schizophrenia compared with healthy volunteers).

    “We found that patients had significantly decreased relative LTL (p = 0.006)”

    Humansschizophrenia compared with healthy volunteersleukocyten = 150

    Telomere Shortening and Its Association with Oxidative Stress and Telomere Maintenance Genes in Schizophrenia

    Sains Malaysiana

  2. Schizophrenia is associated with telomere length in humans (compared with non-psychiatric controls) (effect of diagnosis F3 = 31.870; p = 1.08 × 10−15).

    “TL was shorter in SZ and in MDD compared to NPC”

    Humanscompared with non-psychiatric controlsT-lymphocytes

    Telomere attrition and inflammatory load in severe psychiatric disorders and in response to psychotropic medications

    Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology

  3. Schizophrenia is associated with telomere length in humans (compared to HC).

    “SZ had shorter TL compared to HC”

    Humanscompared to HC

    Telomere length in subjects with schizophrenia, their unaffected siblings and healthy controls: Evidence of accelerated aging

    Schizophrenia research

  4. Schizophrenia is associated with telomere length in humans (standardised mean difference approximately -0.4 to -0.5).

    “At the mechanistic level, meta-analyses reported consistent telomere shortening (standardised mean difference approximately -0.4 to -0.5) and modest acceleration of selected epigenetic clocks.”

    Review

    Schizophrenia and accelerated ageing: systematic review and future research directions

    The British journal of psychiatry : the journal of mental science

  5. Schizophrenia is associated with telomere length in humans (schizophrenia) (SMD = 0.35, 95 % CI 0.11 to 0.60; p=<0.0001).

    “telomere length was shorter in patients with schizophrenia (SMD = 0.35, 95 % CI 0.11 to 0.60; p=<0.0001)”

    Reviewschizophrenia

    Pharmacological interventions and telomere length in patients with schizophrenia and bipolar disorder: A systematic review and meta-analysis

    Journal of psychiatric research

  6. Schizophrenia is associated with telomere length.

    “shortened telomeres reported in these psychopathologies”

    Review

    Telomeres and Psychological Stress: Perspective on Psychopathologies

    Noro psikiyatri arsivi

More on Telomere length

Biological age

upin humans4

4 studies
  1. Schizophrenia is associated with biological age in humans (schizophrenia).

    “transcriptomic data in schizophrenia brain samples further confirms that schizophrenia is associated with accelerated aging.”

    Humansschizophreniabrain

    Accelerated Aging Signatures in 3D Genome Organization and Transcriptome in Schizophrenia

    bioRxiv (Cold Spring Harbor Laboratory)Preprint

  2. Schizophrenia is associated with biological age in humans.

    “Disease- and age-associated sncRNAs and mRNAs revealed accelerated aging in both SCZ and BD.”

    Humansprefrontal cortex

    Several novel classes of small regulatory RNAs show widespread changes in schizophrenia and bipolar disorder and extensive linkages to critical brain processes

    Translational psychiatry

  3. Schizophrenia is associated with biological age in humans (older age).

    “schizophrenia may be associated with accelerated aging”

    Reviewolder age

    Aging in Schizophrenia: Clinical, Biological, and Psychosocial Perspectives

    Geriatrics (Basel, Switzerland)

  4. Schizophrenia is associated with biological age in humans.

    “Several lines of evidence suggest schizophrenia is a segmental progeria, that is, some but not all aspects of accelerated aging may be present.”

    Review

    Accelerated aging in schizophrenia and related disorders: Future research

    Schizophrenia research

Mortality

upin humans4+32% increaseHR 11.72–13.37

4 studies
  1. Schizophrenia is linked with a higher risk of mortality in humans (patients with chronic heart disease, excluding cancer) (HR 11.72-13.37 for males, 13.86-16.65 for females for 4-disease combinations).

    “Excluding cancer revealed schizophrenia and dementia as those with the highest mortality impact”

    Humanspatients with chronic heart disease, excluding cancer

    Co-Occurring Diseases and Mortality in Patients With Chronic Heart Disease, Modeling Their Dynamically Expanding Disease Portfolios: Nationwide Register Study

    JMIR cardio

  2. Schizophrenia is associated with mortality in humans (compared to bipolar disorder or major depressive disorder) (AOR = 1.35; 95%CI = 1.04-1.76; p = 0.024).

    “schizophrenia compared to MDD or BD was significantly associated with increased all-cause mortality (AOR = 1.35; 95%CI = 1.04-1.76; p = 0.024)”

    Humanscompared to bipolar disorder or major depressive disorder5-yearn = 564

    Excess mortality and its causes among older adults with schizophrenia versus those with bipolar disorder and major depressive disorder: a 5-year prospective multicenter study

    European archives of psychiatry and clinical neuroscience

  3. Schizophrenia is linked with a higher risk of mortality in 2020 vs 2019 (32.4% increase).

    “The largest increases in mortality risks were observed among patients with schizophrenia (32.4% increase) and bipolar disorder (25.4% increase).”

    Humansin 2020 vs 2019

    Excess deaths from COVID-19 among Medicare beneficiaries with psychiatric diagnoses: Community versus nursing home

    Journal of the American Geriatrics Society

  4. Schizophrenia is associated with mortality in humans (Compared with comparison groups) (Males: RR 2.62, 95% CI 2.35–2.92; females: RR 2.56, 95% CI 2.27–2.87).

    “Both males and females with schizophrenia had increased all-cause mortality vs. comparison groups”

    ReviewCompared with comparison groups

    Sex-stratified mortality estimates in people with schizophrenia: A systematic review and meta-analysis of cohort studies of 2,700,825 people with schizophrenia

    European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology

Type 2 diabetes

upin humans2OR 1.3

2 studies
  1. Schizophrenia is linked with a higher risk of type 2 diabetes in humans (US Veterans) (OR 1.30, 95% CI 1.21-1.40).

    “Veterans with SMI (SZ, MDD, SZA, and BD) had a higher likelihood of experiencing T2D, compared to the NSCs (ORSZ = 1.30, 95% CI = 1.21-1.40”

    HumansUS Veteransn = 543,979

    Psychiatric factors predict type 2 diabetes mellitus in US Veterans

    Schizophrenia (Heidelberg, Germany)

  2. Schizophrenia is associated with type 2 diabetes in humans (patients with schizophrenia) (Pooled prevalence 13.2% (95% CI: 9.1–18.9%)).

    “the pooled prevalence of T2DM was 13.2% (95% CI: 9.1-18.9%).”

    Reviewpatients with schizophrenia

    Diabetes Mellitus in Patients with Schizophrenia: A Systematic Review and Meta-Analysis of Prevalence of Types and Risk Factors

    Diabetes, metabolic syndrome and obesity : targets and therapy

More on Type 2 diabetes

Accelerated biological aging

upin humans2

2 studies
  1. Schizophrenia is associated with accelerated biological aging in schizophrenia.

    “Collectively, available studies point to altered epigenetic aging, telomere attrition, and enhanced pro-inflammatory profiles in SCZ”

    Reviewin schizophrenia

    Accelerated aging in schizophrenia: integrating epigenetic clocks, telomere dynamics, senescence-associated secretory phenotype, and oxidative stress

    European archives of psychiatry and clinical neuroscience

  2. Schizophrenia is associated with accelerated biological aging in humans.

    “Excess mortality and multiple medical age-related comorbidities are indicators of accelerated biological aging.”

    Review

    Accelerated aging in psychiatric disorders: evidence from epigenetic clocks

    Progress in neuro-psychopharmacology & biological psychiatry

Complement system

upin silico2

2 studies
  1. Schizophrenia is associated with complement system in silico (1.42-fold (p = 0.049)).

    “the Reactome Complement Cascade was enriched 1.42-fold (p = 0.049)”

    In silicocardiovascular tissues

    The MHC/Complement-Driven Pruning-to-Plaque Cascade: Genomic Evidence for Immune-Mediated Acceleration of Atherosclerosis in Schizophrenia

    FigsharePreprint

  2. Schizophrenia is associated with complement system in silico (enrichment 1.21-fold, p = 8.48 × 10−10).

    “Schizophrenia showed extreme vascular transcriptomic enrichment in pruning-related immune pathways (enrichment 1.21-fold, p = 8.48 × 10−10; 43 FDR-significant associations, led by complement/MHC loci)”

    In silicovascularn = 59,000

    From Pruning to Plaque: Schizophrenia Genetics Accelerates Vascular Pathology via Peripheral Immune Extension

    Zenodo (CERN European Organization for Nuclear Research)Preprint

More on Complement system

Metabolic syndrome

upin humans2

2 studies
  1. Schizophrenia is associated with metabolic syndrome in Chinese patients with schizophrenia (31.4% (95% CI: 28.8–34.0)).

    “The pooled analysis revealed a combined prevalence of schizophrenia and MetS in China of 31.4% (95% confidence interval: 28.8–34.0).”

    Reviewin Chinese patients with schizophrenian = 34,655

    Prevalence of metabolic syndrome in Chinese patients with schizophrenia: a systematic review and meta-analysis

    BMC psychiatry

  2. Schizophrenia is associated with metabolic syndrome in patients with schizophrenia.

    “MetS is more prevalent in individuals with SCZ and is a major factor that contributes to their reduced lifespan.”

    Reviewin patients with schizophrenia

    Biological Susceptibility of Patients with Schizophrenia to Metabolic Syndrome: A Review

    Alpha psychiatry

More on Metabolic syndrome

Cognitive impairment

upin humans1RR 3.398–4.594

1 study
  1. Cognitive impairment is linked with a higher risk of schizophrenia in patients with pain conditions of the back, neck, and spine (RR: 3.398, 95% CI 2.874–4.017).

    “BD (RR: 4.818 [3.045, 7.624]), SCZ (RR: 3.398 [2.874, 4.017]) and SB (RR: 1.913 [1.340, 2.732]).”

    Humansin patients with pain conditions of the back, neck, and spinethree-year follow-up

    Bidirectional associations between mental health conditions and cognitive impairment in patients with pain conditions of the back, neck, and spine: A population-based study

    PloS one

  2. Schizophrenia is linked with a higher risk of cognitive impairment in patients with pain conditions of the back, neck, and spine (RR: 4.594, 95% CI 3.974–5.312).

    “PC Patients with MHCs had a higher three-year risk for CI, with the largest risk ratios (RR) observed for SCZ (RR: 4.594; 95% Confidence Interval [3.974, 5.312])”

    Humansin patients with pain conditions of the back, neck, and spinethree-year follow-up

    Bidirectional associations between mental health conditions and cognitive impairment in patients with pain conditions of the back, neck, and spine: A population-based study

    PloS one

More on Cognitive impairment

All 125

Trial sponsors

Funding

50 grants since 2018

National Institute of Mental Health$66.6MNational Institute on Drug Abuse$1.6MJapan Society for the Promotion of Science¥18.6M

How this record changed

  1. Summary rewritten as its findings changed.

    As it read before

    Schizophrenia is associated with shorter lifespan, frailty and dementia in human studies; brain imaging studies report older predicted brain age and faster cortical decline. Epigenetic results vary: blood Horvath age is lower in drug-naive first-episode patients, while frontal-cortex DNA methylation age acceleration is unchanged.

  2. Summary rewritten as its findings changed.

    As it read before

    Reviews link schizophrenia in humans to advanced paternal age, cognitive function in older individuals with schizophrenia, and biological age.

  3. Summary written from the findings.

Latest

Dec 2025: 21Jan 2026: 26Feb 2026: 33Mar 2026: 37Apr 2026: 20May 2026: 12Jun 2026: 15Jul 2026: 13Aug 2026: 12Sep 2026: 13Oct 2026: 23Nov 2026: 15240 papers in 12 months
medRxiv

Genetic dementia risk linked to thinking levels and decline

An observational analysis of 11,518 US adults used 26 years of data to distinguish genetic links involving preexisting thinking ability from those involving age-related…An observational analysis of 11,518 US adults used 26 years of data to distinguish genetic links involving preexisting thinking ability from those involving age-related decline.

Preprint: cohort · 11,518 peopleAlzheimer's disease and related dementias
Progress in Neuro-psychopharmacology & Biological Psychiatry

No clear antipsychotic–death link in schizophrenia with dementia

The adjusted hazard ratio—a relative measure of death risk—was 0.976 for early prescriptions versus none recorded, with no statistically significant difference.The adjusted hazard ratio—a relative measure of death risk—was 0.976 for early prescriptions versus none recorded, with no statistically significant difference.

Cohort · 28,506 peopleSchizophrenia
AHA Scientific Sessions 2026 Abstract

Diabetes drugs linked to fewer deaths in serious mental illness

Compared with another diabetes drug class, the medicines were associated with 1.54 percentage points lower mortality over four years in adults with serious mental…Compared with another diabetes drug class, the medicines were associated with 1.54 percentage points lower mortality over four years in adults with serious mental illness.

Cohort studyInterventions

See all 854 papers on schizophrenia